Barnoud Thibaut, Schmidt M Lee, Donninger Howard, Clark Geoffrey J
Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia PA 19104, USA.
Department of Pharmacology and Toxicology, University of Louisville, KY 40202, USA.
Cancer Lett. 2017 Aug 1;400:30-36. doi: 10.1016/j.canlet.2017.04.030. Epub 2017 Apr 26.
The Ras genes are the most frequently mutated oncogenes in human cancer. However, Ras biology is quite complex. While Ras promotes tumorigenesis by regulating numerous growth promoting pathways, activated Ras can paradoxically also lead to cell cycle arrest, death, and Oncogene-Induced Senescence (OIS). OIS is thought to be a critical pathway that serves to protect cells against aberrant Ras signaling. Multiple reports have highlighted the importance of the p53 and Rb tumor suppressors in Ras mediated OIS. However, until recently, the molecular mechanisms connecting Ras to these proteins remained unknown. The RASSF family of tumor suppressors has recently been identified as direct effectors of Ras. One of these members, NORE1A (RASSF5), may be the missing link between Ras-induced senescence and the regulation of p53 and Rb. This occurs both quantitatively, by promoting protein stability, as well as qualitatively via promoting critical pro-senescent post-translational modifications. Here we review the mechanisms by which NORE1A can activate OIS as a barrier against Ras-mediated transformation, and how this could lead to improved therapeutic strategies against cancers having lost NORE1A expression.
Ras基因是人类癌症中最常发生突变的致癌基因。然而,Ras生物学相当复杂。虽然Ras通过调节众多促进生长的信号通路来促进肿瘤发生,但活化的Ras也可能反常地导致细胞周期停滞、死亡和癌基因诱导的衰老(OIS)。OIS被认为是一种关键途径,可保护细胞免受异常Ras信号的影响。多项报告强调了p53和Rb肿瘤抑制因子在Ras介导的OIS中的重要性。然而,直到最近,将Ras与这些蛋白质联系起来的分子机制仍不清楚。肿瘤抑制因子RASSF家族最近被确定为Ras的直接效应器。其中一个成员,NORE1A(RASSF5),可能是Ras诱导的衰老与p53和Rb调节之间缺失的环节。这在数量上通过促进蛋白质稳定性发生,在质量上则通过促进关键的衰老相关翻译后修饰发生。在这里,我们综述了NORE1A激活OIS作为对抗Ras介导的转化屏障的机制,以及这如何导致针对失去NORE1A表达的癌症的改进治疗策略。